114 research outputs found
Awaiting \u3ci\u3eDoe v. Exxon Mobil Corp.\u3c/i\u3e: Advocating the Cautious Use of Executive Opinions in Alien Tort Claims Act Litigation
In June 2001, eleven Indonesian villagers filed suit in a U.S. District Court against Exxon Mobil Corporation for its alleged complicity in human rights abuses in the Indonesian province of Aceh. The plaintiffs asserted jurisdiction and a cause of action pursuant to the Alien Tort Claims Act and the Torture Victim Protection Act, both of which enable foreign nationals to bring international human rights claims in U.S. federal courts. The U.S. Department of State intervened in the suit, expressing its view that federal court adjudication of the plaintiffs\u27 claims could complicate U.S. foreign policy. The State Department opinion raises concern that the Doe v. Exxon Mobil Corp. suit presents a nonjusticiable political question and is unfit for judicial resolution. The outcome of the Exxon Mobil suit will reflect the power of federal courts to remedy human rights violations committed abroad where the executive branch opposes judicial resolution. This Comment argues that the Exxon Mobil court must independently assess the suit\u27s justiciability, disagreeing with executive branch conclusions when necessary. Separation of powers principles prevent the executive branch from mandating which cases federal courts may hear. Justiciability determinations should instead be guided by the principles underlying the political question doctrine, which insist that foreign affairs consequences do not themselves render a suit nonjusticiable. Congress enacted the Alien Tort Claims Act and Torture Victim Protection Act to ensure that individuals harmed by violations of international law could seek a remedy in U.S. courts. The Exxon Mobil court should not ignore this congressional mandate, nor should it ignore established judicial and constitutional doctrines, merely to accommodate executive foreign policy interests
Bioinspired sensing and control for underwater pursuit
Fish in nature have several distinct advantages over traditional propeller driven underwater vehicles including maneuverability and flow sensing capabilities. Taking inspiration from biology, this work seeks to answer three questions related to bioinspired pursuit and apply the knowledge gained therein to the control of a novel, reaction-wheel driven autonomous fish robot. Which factors are most important to a successful pursuit? How might we guarantee capture with underwater pursuit? How might we track the wake of a flapping fish or vehicle?
A technique called probabilistic analytical modeling (PAM) is developed and illustrated by the interactions between predator and prey fish in two case studies that draw on recent experiments. The technique provides a method for investigators to analyze kinematics time series of pursuit to determine which parameters (e.g. speed, flush distance, and escape angles) have the greatest impact on metrics such as probability of survival.
Providing theoretical guarantees of capture become complicated in the case of a swimming fish or bioinspired fish robot because of the oscillatory nature fish motion. A feedback control law is shown to result in forward swimming motion in a desired direction. Analysis of this law in a pursuit scenario yields a condition stating whether capture is guaranteed provided some basic information about the motion of the prey.
To address wake tracking inspiration is taken from the lateral line sensing organ in fish, which is sensitive to hydrodynamic forces in the local flow field. In experiment, an array of pressure sensors on a Joukowski foil estimates and controls flow-relative position in a Karman vortex street using potential flow theory, recursive Bayesian filtering, and trajectory-tracking, feedback control.
The work in this dissertation pushes the state of the art in bioinspired underwater vehicles closer to what can be found in nature. A modeling technique provides a means to determine what is most important to pursuit when designing a vehicle, analysis of a control law shows that a robotic fish is capable of pursuit engagements with capture guarantees, and an estimation framework demonstrates how the wake of a swimming fish or obstacle in the flow can be tracked
A Decision Framework for Allocation of Constellation-Scale Mission Compute Functionality to Ground and Edge Computing
This paper explores constellation-scale architectural trades, highlights dominant factors, and presents a decision framework for migrating or sharing mission compute functionality between ground and space segments. Over recent decades, sophisticated logic has been developed for scheduling and tasking of space assets, as well as processing and exploitation of satellite data, and this software has been traditionally hosted in ground computing. Current efforts exist to migrate this software to ground cloud-based services. The option and motivation to host some of this logic “at the edge” within the space segment has arisen as space assets are proliferated, are interlinked via transport networks, and are networked with multi-domain assets. Examples include edge-based Battle Management, Command, Control, and Communications (BMC3) being developed by the Space Development Agency and future onboard computing for commercial constellations.
Edge computing pushes workload, computation, and storage closer to data sources and onto devices at the edge of the network. Potential benefits of edge computing include increased speed of response, system reliability, robustness to disrupted networks, and data security. Yet, space-based edge nodes have disadvantages including power and mass limitations, constant physical motion, difficulty of physical access, and potential vulnerability to attacks.
This paper presents a structured decision framework with justifying rationale to provide insights and begin to address a key question of what mission compute functionality should be allocated to the space-based edge , and under what mission or architectural conditions, versus to conventional ground-based systems. The challenge is to identify the Pareto-dominant trades and impacts to mission success. This framework will not exhaustively address all missions, architectures, and CONOPs, however it is intended to provide generalized guidelines and heuristics to support architectural decision-making. Via effects-based simulation and analysis, a set of hypotheses about ground- and edge-based architectures are evaluated and summarized along with prior research. Results for a set of key metrics and decision drivers show that edge computing for specific functionality is quantitatively valuable, especially for interoperable, multi-domain, collaborative assets
Exploring lncRNAs associated with human pancreatic islet cell death induced by transfer of adoptive lymphocytes in a humanized mouse model
BackgroundLong noncoding RNA (lncRNA)-mediated posttranscriptional and epigenetic landscapes of gene regulation are associated with numerous human diseases. However, the regulatory mechanisms governing human β-cell function and survival remain unknown. Owing to technical and ethical constraints, studying the direct role of lncRNAs in β-cell function and survival in humans in vivo is difficult. Therefore, we utilized humanized mice with human islets to investigate lncRNA expression using whole transcriptome shotgun sequencing. Our study aimed to characterize lncRNAs that may be crucial for human islet cell function and survival.MethodsHuman β-cell death was induced in humanized mice engrafted with functional human islets. Using these humanized mice harboring human islets with induced β-cell death, we investigated lncRNA expression through whole transcriptome shotgun sequencing. Additionally, we systematically identified, characterized, and explored the regulatory functions of lncRNAs that are potentially important for human pancreatic islet cell function and survival.ResultsHuman islet cell death was induced in humanized mice engrafted with functional human islets. RNA sequencing analysis of isolated human islets, islet grafts from humanized mice with and without induced cell death, revealed aberrant expression of a distinct set of lncRNAs that are associated with the deregulated mRNAs important for cellular processes and molecular pathways related to β-cell function and survival. A total of 10 lncRNA isoforms (SCYL1-1:22, POLG2-1:1, CTRB1-1:1, SRPK1-1:1, GTF3C5-1:1, PPY-1:1, CTRB1-1:5, CPA5-1:1, BCAR1-2:1, and CTRB1-1:4) were identified as highly enriched and specific to human islets. These lncRNAs were deregulated in human islets from donors with different BMIs and with type 2 diabetes (T2D), as well as in cultured human islets with glucose stimulation and induced cell death induced by cytokines. Aberrant expression of these lncRNAs was detected in the exosomes from the medium used to culture islets with cytokines.ConclusionIslet-enriched and specific human lncRNAs are deregulated in human islet grafts and cultured human islets with induced cell death. These lncRNAs may be crucial for human β-cell function and survival and could have an impact on identifying biomarkers for β-cell loss and discovering novel therapeutic targets to enhance β-cell function and survival
Workflow for the generation of expert-derived training and validation data: a view to global scale habitat mapping
Our ability to completely and repeatedly map natural environments at a global scale have increased significantly over the past decade. These advances are from delivery of a range of on-line global satellite image archives and global-scale processing capabilities, along with improved spatial and temporal resolution satellite imagery. The ability to accurately train and validate these global scale-mapping programs from what we will call “reference data sets” is challenging due to a lack of coordinated financial and personnel resourcing, and standardized methods to collate reference datasets at global spatial extents. Here, we present an expert-driven approach for generating training and validation data on a global scale, with the view to mapping the world’s coral reefs. Global reefs were first stratified into approximate biogeographic regions, then per region reference data sets were compiled that include existing point data or maps at various levels of accuracy. These reference data sets were compiled from new field surveys, literature review of published surveys, and from individually sourced contributions from the coral reef monitoring and management agencies. Reference data were overlaid on high spatial resolution satellite image mosaics (3.7 m × 3.7 m pixels; Planet Dove) for each region. Additionally, thirty to forty satellite image tiles; 20 km × 20 km) were selected for which reference data and/or expert knowledge was available and which covered a representative range of habitats. The satellite image tiles were segmented into interpretable groups of pixels which were manually labeled with a mapping category via expert interpretation. The labeled segments were used to generate points to train the mapping models, and to validate or assess accuracy. The workflow for desktop reference data creation that we present expands and up-scales traditional approaches of expert-driven interpretation for both manual habitat mapping and map training/validation. We apply the reference data creation methods in the context of global coral reef mapping, though our approach is broadly applicable to any environment. Transparent processes for training and validation are critical for usability as big data provide more opportunities for managers and scientists to use global mapping products for science and conservation of vulnerable and rapidly changing ecosystems
Management of patients at the hepatopancreatobiliary unit of a London teaching hospital during the COVID-19 pandemic
To mitigate COVID-19-related shortage of treatment capacity, the hepatopancreatobiliary (HPB) unit of the Royal Free Hospital London (RFHL) transferred its practice to independent hospitals in Central London through the North Central London Cancer Alliance. The aim of this study was to critically assess this strategy and evaluate perioperative outcomes. Prospectively collected data were reviewed on all patients who were treated under the RFHL HPB unit in six hospitals between November 2020 and October 2021. A total of 1541 patients were included, as follows: 1246 (81%) at the RFHL, 41 (3%) at the Chase Farm Hospital, 23 (2%) at the Whittington Hospital, 207 (13%) at the Princess Grace Hospital, 12 (1%) at the Wellington Hospital and 12 (1%) at the Lister Hospital, Chelsea. Across all institutions, overall complication rate were 40%, major complication (Clavien-Dindo grade ≥ 3a) rate were 11% and mortality rates were 1.4%, respectively. In COVID-19-positive patients (n = 28), compared with negative patients, complication rate and mortality rates were increased tenfold. Outsourcing HPB patients, including their specialist care, to surrounding institutions was safe and ensured ongoing treatment with comparable outcomes among the institutions during the COVID-19 pandemic. Due to the lack of direct comparison with a non-pandemic cohort, these results can strictly only be applied within a pandemic setting
Quality assessment of a sample of mobile app-based health behavior change interventions using a tool based on the National Institute of Health and Care Excellence behavior change guidance
Objective: To quality assess a sample of health behavior change apps from the NHS Apps Library using a rating tool based on the 2014 National Institute for Health and Care Excellence behavior change guidance (NICE BCG).
Methods: A qualitative analysis of the NICE BCG identified themes and questions for a quality assessment of health behavior change apps. These were refined by further discussion and piloting, and applied by two independent raters to a sample of NHS Library apps (N=49). Disagreements were resolved following discussions with a third rater.
Results: Themes identified were; purpose, planning, usability, tailoring, behavior change technique (BCT), maintenance, evaluation, data security and documentation. Overall, purpose of the apps was clear, but evidence for collaboration with users or professionals was lacking. Usability information was poor and tailoring disappointing. Most used recognized BCTs but paid less attention to behavior maintenance than initiation. Information on app evaluation and documentation was sparse.
Conclusions: This study furthers the work of the NHS apps library, adapting the NICE (2014) behavior change guidance for quality assessment of behavior change apps.
Practice Implications: This study helps lay the foundations for development of a quality assurance tool for mobile health apps aimed at health behavior change
Author Correction: Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk
Correction to: Nature Geneticshttps://doi.org/10.1038/s41588-023-01314-0, published online 13 March 2023. In the version of the article initially published, the sample sizes in the main text and Supplementary Tables 1 and 2 were incorrect. In the abstract, the last paragraph of the Introduction, the first paragraph of the Results, the top box in Figure 1a and the Supplementary Information, the total sample size has been corrected from 580,869 to 588,452 participants and the size of the European cohort from 468,062 to 475,645. Some of the effect sizes in Supplementary Table 14 (columns W, Z, AC, AF) had the wrong sign. There was also an error in Supplementary Table 3 where the sample size instead of the variant count was shown for EXCEED. The errors do not affect the conclusions of the study. Additionally, two acknowledgments for use of INTERVAL pQTL and Lung eQTL consortium data were omitted from the Supplementary Information. These errors have been corrected in the Supplementary Information and HTML and PDF versions of the article
The impact of digital health technologies on tuberculosis treatment : a systematic review
Digital technologies are increasingly harnessed to support treatment of persons with tuberculosis (TB). Since in-person directly observed treatment (DOT) can be resource intensive and challenging to implement, these technologies may have the potential to improve adherence and clinical outcomes. We reviewed the effect of these technologies on TB treatment adherence and patient outcomes. We searched several bibliographical databases for studies reporting the effect of digital interventions, including short message service (SMS), video-observed therapy (VOT) and medication monitors (MMs), to support treatment for active TB. Only studies with a control group and which reported effect estimates were included. Four trials showed no statistically significant effect on treatment completion when SMS was added to standard care. Two observational studies of VOT reported comparable treatment completion rates when compared with in-person DOT. MMs increased the probability of cure (RR 2.3, 95% CI 1.6-3.4) in one observational study, and one trial reported a statistically significant reduction in missed treatment doses relative to standard care (adjusted means ratio 0.58, 95% CI 0.42-0.79). Evidence of the effect of digital technologies to improve TB care remains limited. More studies of better quality are needed to determine how such technologies can enhance programme performance
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
Background: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28–2·40], p\textless0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65–3·22], p\textless0·0001), American Society of Anesthesiologists grades 3–5 versus grades 1–2 (2·35 [1·57–3·53], p\textless0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01–2·39], p=0·046), emergency versus elective surgery (1·67 [1·06–2·63], p=0·026), and major versus minor surgery (1·52 [1·01–2·31], p=0·047). Interpretation: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding: National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research
- …